Popik P - Search Results

1

Dopamine D2/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress.

Malikowska-Racia N, Sałat K, Nowaczyk A, Fijałkowski Ł, Popik P. Malikowska-Racia N, et al. Among authors: popik p. Neuropharmacology. 2019 Sep 1;155:1-9. doi: 10.1016/j.neuropharm.2019.05.012. Epub 2019 May 11. Neuropharmacology. 2019. PMID: 31085186

2

Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists.

Popik P, Mamczarz J, Fraczek M, Widła M, Hesselink M, Danysz W. Popik P, et al. Neuropharmacology. 1998 Aug;37(8):1033-42. doi: 10.1016/s0028-3908(98)00105-1. Neuropharmacology. 1998. PMID: 9833632

3

Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models.

Kłodzińska A, Chojnacka-Wójcik E, Pałucha A, Brański P, Popik P, Pilc A. Kłodzińska A, et al. Among authors: popik p. Neuropharmacology. 1999 Dec;38(12):1831-9. doi: 10.1016/s0028-3908(99)00066-0. Neuropharmacology. 1999. PMID: 10608278

4

Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence.

Popik P, Wróbel M, Nowak G. Popik P, et al. Neuropharmacology. 2000 Sep;39(12):2278-87. doi: 10.1016/s0028-3908(00)00090-3. Neuropharmacology. 2000. PMID: 10974311

5

Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist.

Popik P, Wróbel M. Popik P, et al. Neuropharmacology. 2002 Dec;43(8):1210-7. doi: 10.1016/s0028-3908(02)00309-x. Neuropharmacology. 2002. PMID: 12527470

6

Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner.

Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P. Nikiforuk A, et al. Among authors: popik p. Neuropharmacology. 2011 Jul-Aug;61(1-2):262-7. doi: 10.1016/j.neuropharm.2011.04.010. Epub 2011 Apr 21. Neuropharmacology. 2011. PMID: 21530555

7

Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.

Nikiforuk A, Kos T, Hołuj M, Potasiewicz A, Popik P. Nikiforuk A, et al. Among authors: popik p. Neuropharmacology. 2016 Feb;101:389-400. doi: 10.1016/j.neuropharm.2015.07.034. Epub 2015 Jul 29. Neuropharmacology. 2016. PMID: 26232639

8

Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.

Sałat K, Siwek A, Starowicz G, Librowski T, Nowak G, Drabik U, Gajdosz R, Popik P. Sałat K, et al. Among authors: popik p. Neuropharmacology. 2015 Dec;99:301-7. doi: 10.1016/j.neuropharm.2015.07.037. Epub 2015 Aug 1. Neuropharmacology. 2015. PMID: 26240948

9

Anandamide mediates cognitive judgement bias in rats.

Kregiel J, Malek N, Popik P, Starowicz K, Rygula R. Kregiel J, et al. Among authors: popik p. Neuropharmacology. 2016 Feb;101:146-53. doi: 10.1016/j.neuropharm.2015.09.009. Epub 2015 Sep 9. Neuropharmacology. 2016. PMID: 26363193

10

The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.

Nikiforuk A, Hołuj M, Kos T, Popik P. Nikiforuk A, et al. Among authors: popik p. Neuropharmacology. 2016 Jun;105:351-360. doi: 10.1016/j.neuropharm.2016.01.035. Epub 2016 Jan 28. Neuropharmacology. 2016. PMID: 26826431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters